- Text-only version of this website
- Skip navigation
- Home page
- What's new
- Search
- Contact Webmaster
- Website policies
- Disability services
Dr. Josh Brown receives AMCP’s 2019 New Practitioner Award
AMCP gives the award to a member who has made a significant contribution to managed care pharmacy within five years of graduation.
Study finds sepsis patients at risk of antibiotic resistance when subjected to continual broad antibiotic use
Dr. Scott Martin Vouri co-authored the study published in the journal Pharmacotherapy.
New machine-learning model found effective at predicting risk of opioid overdose
The model allows scientists to assess complex interactions of large data that can reveal hidden patterns and generate more accurate predictions in clinical settings.
UF study questions accuracy of CMS opioid safeguards
The Centers for Medicare and Medicaid Services criteria are used to flag high-risk patients for opioid abuse and overdose.
Dr. Scott Martin Vouri named a Claude D. Pepper Junior Scholar
The distinction comes with a two-year, $104,000 award, which Vouri will use to study a type of drug-induced adverse event called a prescribing cascade in older adults.
Dr. Amie Goodin featured in NY Times story on the opioid crisis
“Current policies to limit opioid prescriptions leave some pain patients high and dry, resulting in a new wave of unintended consequences for patients with untreated chronic pain.”
Welcome to the Department of Pharmaceutical Outcomes and Policy
Thank you for your interest in our department, and our outstanding faculty, students and staff who represent our broad range of programs and resources. Faculty are actively engaged in the entry-level Pharm.D. program and our own graduate program, including one of the nation’s largest Ph.D. programs in pharmaceutical outcomes and policy, a research-focused residential M.S. program and an applied online M.S. program geared toward working professionals.
The department’s focus in research and graduate training is centered on the evaluation of drugs and related medical technology. This focus includes classic pharmacoepidemiologic and pharmacoeconomic work, as well as pharmaceutical health services research with a focus on quality and policy involving medication use. Our program has grown tremendously over the past five years with more to come. To find out more, please refer to our annual report and reach out or visit us in beautiful Florida to see one of the nation’s top 10 universities and top 10 pharmacy colleges.
Almut G. Winterstein, Ph.D.
Department Chair
2018 Annual Report
Events
POP Seminar Announcement: Motomori Lewis
Motomori Lewis is a first year PhD student who joined the POP program in Fall 2018. Motomori received her Bachelors in Public Health and Bachelors in Biomedical Sciences from the […]
POP Seminar Announcement: Xi Wang
Xi Wang received her bachelor’s degree from Xiangya School of Medicine, Central South University, China and her Master of Public Health in epidemiology from Emory University. Xi’s desires to become […]